Angiotensin-Converting Enzyme Inhibitor Washout Period Prior to Angiotensin Receptor/Neprilysin Inhibitor Initiation in the Inpatient Setting
This is the first study to our knowledge to describe real-world prescribing practices when transitioning patients from ACEi to ARNI for the treatment of HFrEF. Larger, multicenter studies are needed to provide more data on prescribing practices outside this single center. Future research should also include pharmacist's role in adhering to the recommended washout.
Authors
- Bryn Lindley (ORCID: https://orcid.org/0000-0001-5861-4441)
- Jessica M Schillig
- Quang Nguyen (ORCID: https://orcid.org/0009-0000-6309-855X)
- Brittany N. Palasik (ORCID: https://orcid.org/0000-0001-7802-4182)
- Meredith L. Howard (ORCID: https://orcid.org/0000-0003-4514-3948)
- Kaanan Shah
- Stella Mabhugu
- Jessica Obioma
Institutions
- University of North Texas (US)
- Amgen (United States) (US)
- University of North Texas Health Science Center (US)
- Henry Ford Hospital (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Montana (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1177/10600280241282324
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00